These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28337724)

  • 1. I-123 iomazenil single photon emission computed tomography for detecting loss of neuronal integrity in patients with traumatic brain injury.
    Abiko K; Ikoma K; Shiga T; Katoh C; Hirata K; Kuge Y; Kobayashi K; Tamaki N
    EJNMMI Res; 2017 Dec; 7(1):28. PubMed ID: 28337724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired neuronal integrity in traumatic brain injury detected by
    Kato H; Nakagawara J; Hachisuka K; Hatazawa J; Ikoma K; Suehiro E; Iida H; Ogasawara K; Iizuka O; Ishiai S; Ichikawa T; Nariai T; Okazaki T; Shiga T; Mori E
    J Cereb Blood Flow Metab; 2022 Dec; 42(12):2245-2254. PubMed ID: 35796498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of benzodiazepine receptors using iodine-123-labeled iomazenil single-photon emission computed tomography in patients with ischemic cerebrovascular disease. A comparison with PET study.
    Dong Y; Fukuyama H; Nabatame H; Yamauchi H; Shibasaki H; Yonekura Y
    Stroke; 1997 Sep; 28(9):1776-82. PubMed ID: 9303025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovered neuronal viability revealed by Iodine-123-iomazenil SPECT following traumatic brain injury.
    Koizumi H; Fujisawa H; Kurokawa T; Suehiro E; Iwanaga H; Nakagawara J; Suzuki M
    J Cereb Blood Flow Metab; 2010 Oct; 30(10):1673-81. PubMed ID: 20683454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preserved benzodiazepine receptors in Alzheimer's disease measured with C-11 flumazenil PET and I-123 iomazenil SPECT in comparison with CBF.
    Ohyama M; Senda M; Ishiwata K; Kitamura S; Mishina M; Ishii K; Toyama H; Oda K; Katayama Y
    Ann Nucl Med; 1999 Oct; 13(5):309-15. PubMed ID: 10582800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical damage following traumatic brain injury evaluated by iomazenil SPECT and in vivo microdialysis.
    Koizumi H; Fujisawa H; Suehiro E; Iwanaga H; Nakagawara J; Suzuki M
    Acta Neurochir Suppl; 2013; 118():121-3. PubMed ID: 23564116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the addition of
    Ogasawara K; Takahashi T; Igarashi S; Yabuki M; Omori D; Akamatsu Y; Chida K; Kobayashi M; Fujiwara S; Terasaki K
    Ann Nucl Med; 2023 May; 37(5):280-288. PubMed ID: 36805493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with 123I-iomazenil SPECT in acute cerebral infarction.
    Müller V; Saur D; Klutmann S; Weiller C; Röther J; Clausen M
    Nucl Med Commun; 2002 Dec; 23(12):1191-6. PubMed ID: 12464784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodine-123-iomazenil and iodine-123-iodoamphetamine SPECT in major cerebral artery occlusive disease.
    Moriwaki H; Matsumoto M; Hashikawa K; Oku N; Ishida M; Seike Y; Fukuchi K; Hori M; Nishimura T
    J Nucl Med; 1998 Aug; 39(8):1348-53. PubMed ID: 9708504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of early and late images on 123I-iomazenil SPECT with cerebral blood flow and oxygen extraction fraction images on PET in the cerebral cortex of patients with chronic unilateral major cerebral artery occlusive disease.
    Suzuki T; Ogasawara K; Kuroda H; Chida K; Aso K; Kobayashi M; Fujiwara S; Yoshida K; Terasaki K; Ogawa A
    Nucl Med Commun; 2012 Feb; 33(2):171-8. PubMed ID: 22095318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-surgical identification of epileptogenic areas in temporal lobe epilepsy by 123I-iomazenil SPECT: a comparison with IMP SPECT and FDG PET.
    Kaneko K; Sasaki M; Morioka T; Koga H; Abe K; Sawamoto H; Ohya N; Yoshiura T; Mihara F; Honda H
    Nucl Med Commun; 2006 Nov; 27(11):893-9. PubMed ID: 17021430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzodiazepine receptors in chronic cerebrovascular disease: comparison with blood flow and metabolism.
    Sasaki M; Ichiya Y; Kuwabara Y; Yoshida T; Fukumura T; Masuda K
    J Nucl Med; 1997 Nov; 38(11):1693-8. PubMed ID: 9374335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Benzodiazepine receptor and cerebral blood flow in early Alzheimer's disease--SPECT study using 123I-iomazenil and 123I-IMP].
    Kitamura S; Koshi Y; Komiyama T; Sakayori O; Komaba Y; Ohyama M; Mishina M; Tsuganesawa T; Terashi A
    Kaku Igaku; 1996 Jan; 33(1):49-56. PubMed ID: 8819714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Binding Potential of Brain Adenosine A
    Hayashi S; Inaji M; Nariai T; Oda K; Sakata M; Toyohara J; Ishii K; Ishiwata K; Maehara T
    J Neurotrauma; 2018 Jan; 35(1):25-31. PubMed ID: 28728462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal neuronal damage in patients with neuropsychological impairment after diffuse traumatic brain injury: evaluation using ¹¹C-flumazenil positron emission tomography with statistical image analysis.
    Kawai N; Maeda Y; Kudomi N; Yamamoto Y; Nishiyama Y; Tamiya T
    J Neurotrauma; 2010 Dec; 27(12):2131-8. PubMed ID: 21138392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET measurement of "GABA shift" in the rat brain: A preclinical application of bolus plus constant infusion paradigm of [
    Kim W; Park HS; Moon BS; Lee BC; Kim SE
    Nucl Med Biol; 2017 Feb; 45():30-34. PubMed ID: 27886620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative estimation of I-123-Iomazenil receptor binding in temporal lobe epilepsies using two SPECT acquisitions--comparison with the regional cerebral blood flow and a compartment model.
    Venz S; Hierholzer J; Cordes M; Straub HB; Keske U; Meencke HJ; Eichstädt H; Felix R
    Nuklearmedizin; 1998 Mar; 37(2):49-56. PubMed ID: 9547750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double match of
    Fujimoto A; Okanishi T; Kanai S; Sato K; Itamura S; Baba S; Nishimura M; Masui T; Enoki H
    Acta Neurochir (Wien); 2018 Sep; 160(9):1875-1882. PubMed ID: 29858947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phase 2 clinical study of 123I-iomazenil in various cerebral diseases: part 2--clinical evaluation of central-type benzodiazepine receptor imaging with 123I-iomazenil SPECT].
    Torizuka K; Uemura K; Thoru M; Yonekura Y; Nakagawara J; Fukuyama H; Matsuda K; Morimoto K
    Kaku Igaku; 1996 Feb; 33(2):191-205. PubMed ID: 8721108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-flumazenil: a γ-aminobutyric acid A-specific PET radiotracer for the localization of drug-resistant temporal lobe epilepsy.
    Vivash L; Gregoire MC; Lau EW; Ware RE; Binns D; Roselt P; Bouilleret V; Myers DE; Cook MJ; Hicks RJ; O'Brien TJ
    J Nucl Med; 2013 Aug; 54(8):1270-7. PubMed ID: 23857513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.